FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019222733> ?p ?o ?g. }

• W2019222733 endingPage "184" @default.
• W2019222733 startingPage "172" @default.
• W2019222733 abstract "The purpose of this research is to evaluate <i>Sterculia urens</i> gum as a carrier for a colon-targeted drug delivery system. Microflora degradation studies of Sterculia gum was conducted in phosphate-buffered saline pH 7.4 containing rat caecal medium under an anaerobic environment. Solubility, swelling index, viscosity, and pH of the polymer solution were determined. Different formulation aspects considered were gum concentration (10–40%) and concentration of citric acid (10–30%) on the swelling index and in-vitro dissolution release. The results of the isothermal stress testing showed that there is no degradation of samples of model drug, azathioprine, the drug polymer mixture, and the core tablet excipients. Differential scanning calorimetry and Fourier transform infrared spectroscopy study proved the compatibility of the drug with Sterculia gum and other tablet excipients. Microflora degradation study revealed that Sterculia gum can be used as tablet excipient for drug release in the colonic region by utilizing the action of enterobacteria. The swelling force of the Sterculia gum could concurrently drive the drug out of the polysaccharide core due to the rupture of the mixed film coating under colonic microflora–activated environment. Sterculia gum gives premature drug release in the upper gastrointestinal tract without enteric coating and may not reach the colonic region. Sterculia gum as a colon-targeting carrier is possible via double-layer coating with chitosan/Eudragit RLPO (ammonio-methacrylate copolymer) mixed blend as well as enteric polymers, which would provide acid as well as intestinal resistance but undergo enzymatic degradation once reaching the colon. <i>LAY ABSTRACT:</i> The aim of the research is to evaluate wheather <i>Sterculia urens,</i> which is a polysaccharide, is suitable as a carrier for colonic delivery of drugs acting locally in the colon. Sterculia gum has been reported to have wide pharmaceutical applications such as tablet binder, disintegrant, gelling agent, and as a controlled release polymer. Sterculia gum falls under the category of a polysaccharide and is yet to be evaluated as a carrier for colonic delivery of drugs. First the susceptibility of the polysaccharide gum in rat caecal microflora was investigated because true polysaccharides are degraded by the action of normal colonic bacteria. Bacterial degradation of the gum in the colonic environment was confirmed by adding a small quantity of the gum in rat caecal content mixed with phosphate-buffered saline pH 7.4 under an anaerobic environment. Solubility, swelling index, viscosity, and pH of the polymer solution were determined. Different formulation aspects considered were gum concentration (10–40%), concentration of citric acid (10–30%) on swelling index, and in vitro dissolution behavior. Isothermal stress testing was done to determine that there was no degradation of the model drug, azathioprine, with Sterculia gum excipient mixtures under stressed conditions. Differential scanning calorimetry and Fourier transform infrared spectroscopy study proved the compatibility of the drug with Sterculia gum and other tablet excipients. Microflora degradation study revealed that Sterculia gum is digested by the colonic microflora and therefore can be used as a tablet excipient for drug release in the colonic region utilizing the microflora degradation mechanism. Sterculia gum gives premature drug release in the upper gastrointestinal tract without enteric coating and may not reach the colonic region. Sterculia gum as colon-targeting carrier is possible via double-layer coating with chitosan/Eudragit RLPO (ammonio-methacrylate copolymer) and Eudragit L100 polymers, which would provide acid as well as intestinal resistance but undergo enzymatic degradation once reaching the colon." @default.
• W2019222733 created "2016-06-24" @default.
• W2019222733 creator A5035013216 @default.
• W2019222733 creator A5061170602 @default.
• W2019222733 date "2013-03-01" @default.
• W2019222733 modified "2023-09-25" @default.
• W2019222733 title "Studies on Stercuia Gum Formulations in the Form of Osmotic Core Tablet for Colon-Specific Drug Delivery of Azathioprine" @default.
• W2019222733 cites W187050879 @default.
• W2019222733 cites W1968988805 @default.
• W2019222733 cites W1990129537 @default.
• W2019222733 cites W2004868362 @default.
• W2019222733 cites W2011437763 @default.
• W2019222733 cites W2044883409 @default.
• W2019222733 cites W2050013673 @default.
• W2019222733 cites W2052073351 @default.
• W2019222733 cites W2060236861 @default.
• W2019222733 cites W2067925169 @default.
• W2019222733 cites W2070619639 @default.
• W2019222733 cites W2078223344 @default.
• W2019222733 cites W2093364448 @default.
• W2019222733 cites W2115786024 @default.
• W2019222733 cites W2129105416 @default.
• W2019222733 cites W2140109961 @default.
• W2019222733 cites W2276100660 @default.
• W2019222733 cites W2526386021 @default.
• W2019222733 cites W3145664415 @default.
• W2019222733 doi "https://doi.org/10.5731/pdajpst.2013.00913" @default.
• W2019222733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23569078" @default.
• W2019222733 hasPublicationYear "2013" @default.
• W2019222733 type Work @default.
• W2019222733 sameAs 2019222733 @default.
• W2019222733 citedByCount "6" @default.
• W2019222733 countsByYear W20192227332016 @default.
• W2019222733 countsByYear W20192227332017 @default.
• W2019222733 countsByYear W20192227332019 @default.
• W2019222733 countsByYear W20192227332021 @default.
• W2019222733 crossrefType "journal-article" @default.
• W2019222733 hasAuthorship W2019222733A5035013216 @default.
• W2019222733 hasAuthorship W2019222733A5061170602 @default.
• W2019222733 hasConcept C159985019 @default.
• W2019222733 hasConcept C178790620 @default.
• W2019222733 hasConcept C185592680 @default.
• W2019222733 hasConcept C192562407 @default.
• W2019222733 hasConcept C2776725572 @default.
• W2019222733 hasConcept C2778540859 @default.
• W2019222733 hasConcept C2779732960 @default.
• W2019222733 hasConcept C2779820397 @default.
• W2019222733 hasConcept C31903555 @default.
• W2019222733 hasConcept C43617362 @default.
• W2019222733 hasConceptScore W2019222733C159985019 @default.
• W2019222733 hasConceptScore W2019222733C178790620 @default.
• W2019222733 hasConceptScore W2019222733C185592680 @default.
• W2019222733 hasConceptScore W2019222733C192562407 @default.
• W2019222733 hasConceptScore W2019222733C2776725572 @default.
• W2019222733 hasConceptScore W2019222733C2778540859 @default.
• W2019222733 hasConceptScore W2019222733C2779732960 @default.
• W2019222733 hasConceptScore W2019222733C2779820397 @default.
• W2019222733 hasConceptScore W2019222733C31903555 @default.
• W2019222733 hasConceptScore W2019222733C43617362 @default.
• W2019222733 hasIssue "2" @default.
• W2019222733 hasLocation W20192227331 @default.
• W2019222733 hasLocation W20192227332 @default.
• W2019222733 hasOpenAccess W2019222733 @default.
• W2019222733 hasPrimaryLocation W20192227331 @default.
• W2019222733 hasRelatedWork W1964082862 @default.
• W2019222733 hasRelatedWork W1966852571 @default.
• W2019222733 hasRelatedWork W2058617118 @default.
• W2019222733 hasRelatedWork W2095185658 @default.
• W2019222733 hasRelatedWork W2260874361 @default.
• W2019222733 hasRelatedWork W2328012347 @default.
• W2019222733 hasRelatedWork W2363560281 @default.
• W2019222733 hasRelatedWork W2899084033 @default.
• W2019222733 hasRelatedWork W4220776040 @default.
• W2019222733 hasRelatedWork W4307965023 @default.
• W2019222733 hasVolume "67" @default.
• W2019222733 isParatext "false" @default.
• W2019222733 isRetracted "false" @default.
• W2019222733 magId "2019222733" @default.
• W2019222733 workType "article" @default.